Terry Vance serves as Executive at ENANTA PHARMACEUTICALS INC, where they oversee executive responsibilities. Since joining the company, Terry Vance has executed 4 insider transactions totaling $379.7K, demonstrating a bullish approach to their equity position. Their most recent transaction on Dec 13, 2023 involved selling 15,295 shares valued at $139.5K.
Terry Vance currently holds 5,800 shares of ENANTA PHARMACEUTICALS INC (ENTA), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Terry Vance has been a net buyer of ENTA stock. They have purchased $240.2K and sold $139.5K worth of shares.
Terry Vance's most recent insider trade was on Dec 13, 2023, when they sold 15,295 shares at $9.12 per share.
Get notified when new Form 4 filings are submitted
| $14.00 |
| Discretionary |
| Feb 12, 2016 | ENTA | $54.1K | Purchase | 2,000 | $27.04 | Discretionary |
| Mar 26, 2013 | ENTA | $186.1K | Purchase | 13,295 | $14.00 | Discretionary |